# EDGAR Filing Document

**Accession Number:** 0001306830
**File Stem:** 0001306830-25-000205
**Filing Date:** 2025-10
**Character Count:** 14029
**Document Hash:** a1451fc9500b31aee014ea824d07d8d0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001306830-25-000205.hdr.sgml**: 20251028

**ACCESSION NUMBER**: 0001306830-25-000205

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20251028

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20251028

**DATE AS OF CHANGE**: 20251028

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Celanese Corp
- **CENTRAL INDEX KEY:** 0001306830
- **STANDARD INDUSTRIAL CLASSIFICATION:** PLASTIC MATERIAL, SYNTH RESIN/RUBBER, CELLULOS (NO GLASS) [2820]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 980420726
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-32410
- **FILM NUMBER:** 251425487

**BUSINESS ADDRESS:**
- **STREET 1:** 222 W. LAS COLINAS BLVD., SUITE 900N
- **CITY:** IRVING
- **STATE:** TX
- **ZIP:** 75039-5421
- **BUSINESS PHONE:** 972-443-4000

**MAIL ADDRESS:**
- **STREET 1:** 222 W. LAS COLINAS BLVD., SUITE 900N
- **CITY:** IRVING
- **STATE:** TX
- **ZIP:** 75039-5421

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Celanese CORP
- **DATE OF NAME CHANGE:** 20041102

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Blackstone Crystal Holdings Capital Partners (Cayman) IV Ltd.
- **DATE OF NAME CHANGE:** 20041022

?xml version='1.0' encoding='ASCII'? ce-20251028

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K** 

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): **October 28, 2025 (October 28, 2025)**

**CELANESE CORPORATION** 

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-32410** | **98-0420726** |
| (State or other jurisdiction<br>of incorporation) | (Commission File<br>Number) | (IRS Employer<br>Identification No.) |

---

**222 West Las Colinas Blvd. Suite 900N, Irving, TX 75039** 

(Address of Principal Executive Offices) (Zip Code)

Registrant's telephone number, including area code: **(972) 443-4000** 

**N/A**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **<u>Title of Each Class</u>** | **<u>Trading Symbol(s)</u>** |  **<u>Name of Each Exchange on Which Registered</u>** |
| **Common Stock, par value $0.0001 per share** | **CE** | **New York Stock Exchange** |
| **4.777% Senior Notes due 2026** | **CE /26A** | **New York Stock Exchange** |
| **2.125% Senior Notes due 2027** | **CE /27** | **New York Stock Exchange** |
| **0.625% Senior Notes due 2028** | **CE /28** | **New York Stock Exchange** |
| **5.337% Senior Notes due 2029** | **CE /29A** | **New York Stock Exchange** |
| **5.000% Senior Notes due 2031** | **CE /31** | **New York Stock Exchange** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

---

| | |
|:---|:---|
| **Item 7.01** | **Regulation FD Disclosure** |

---

On October 28, 2025, Celanese Corporation (the "Company") announced the signing of a purchase and sale agreement with Element Solutions Inc to divest the Company's Micromax® portfolio of products.

*Press Release*

A copy of the press release announcing the above-referenced transaction is furnished as Exhibit 99.1 to this Current Report on Form 8-K (this "Current Report").

***Forward-Looking Statements***

*The information set forth in this Current Report contains certain "forward-looking statements," which include information concerning the expected timing of the closing of the transaction, the Company's plans, objectives, goals, future revenues, financial performance, deleveraging efforts, and other information that is not historical information. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained herein. These include, but are not limited to, the Company's ability to obtain regulatory approval for and satisfy closing conditions to the transactions described herein, the timing of closing thereof, and the Company's ability to realize the anticipated benefits of the transactions described herein. Numerous factors, many of which are beyond the Company's control could cause actual results to differ materially from those expressed as forward-looking statements. Certain of these risk factors are discussed under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 and other filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date it is made, and the Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date the statement is made.*

---

| | |
|:---|:---|
| **Item 9.01** | **Financial Statements and Exhibits** |

---

(d) The following exhibits are being filed herewith:

---

| | |
|:---|:---|
| **Exhibit<br>Number** | |
| **Exhibit<br>Number** |<br>**Description** |
| 99.1 | <u>[P](a202510xxex991projectmatti.htm)[ress Release dated October](a202510xxex991projectmatti.htm)[28](a202510xxex991projectmatti.htm)[, 2025.\*](a202510xxex991projectmatti.htm)</u> |
| 104 | Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document contained in Exhibit 101) |

---

\* In connection with the disclosure set forth in Item 7.01, the information in this Current Report, including the exhibits attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section. The information in this Current Report, including the exhibits, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference language in any such filing. This Current Report will not be deemed an admission as to the materiality of any information in this Current Report that is required to be disclosed solely by Regulation FD.

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| **CELANESE CORPORATION** | **CELANESE CORPORATION** |
| By: | /s/ ASHLEY B. DUFFIE |
| Name: | Ashley B. Duffie |
| Title: | Senior Vice President, General Counsel and Corporate Secretary |
| Date: | October 28, 2025 |

---

## Exhibit 99.1

**Exhibit 99.1**

![picture2.jpg](picture2.jpg)

**News Release**

---

| |
|:---|
| **Celanese Corporation** |
| 222 West Las Colinas Blvd. |
| Suite 900N |
| Irving, Texas 75039 |

---

**Celanese Announces Agreement to Divest Micromax® Business**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Purchase price of approximately $500 million, subject to adjustment, net proceeds of which will be dedicated to deleveraging*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Current pro forma run rate EBITDA of the business in 2025 is approximately $40 million*

**DALLAS, October 28, 2025** (BUSINESS WIRE) – Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, announced today it has signed a definitive agreement to divest the Micromax<sup>®</sup> portfolio of products to Element Solutions Inc (NYSE: ESI). Under the terms of the agreement, Celanese will receive approximately $500 million in cash, subject to adjustments.

"The agreement to divest Micromax benefits Celanese and our shareholders, and we are pleased to have run a successful process that maximizes the value of the asset," said Scott Richardson, President and Chief Executive Officer of Celanese. "In addition to the value created, the transaction and our commitment to use the transaction proceeds to pay down debt highlight how we are aggressively and prudently taking steps to deleverage our balance sheet. This is an important milestone in our journey as we continue to execute against our key priorities, and we are excited for the opportunities the Micromax team will have as part of Element Solutions."

"Micromax is a great fit for Element Solutions, enhancing our Electronics business' customer value proposition and the breadth of high-value solutions we can offer to our supply chain," said Benjamin Gliklich, Chief Executive Officer of Element Solutions. "The Micromax product portfolio aligns with our core competencies in formulations capability and metals expertise with a high-touch, low capital intensity operating model. Equally importantly, the business brings a proven team of experienced, highly technical leaders in adjacent electronics materials segments."

The transaction is expected to close in the first quarter of 2026, subject to certain regulatory approvals and customary closing conditions.

Morgan Stanley & Co. LLC is acting as financial advisor to Celanese on the transaction, and Kirkland & Ellis LLP and Allen Overy Shearman Sterling LLP are providing legal counsel.

For more information on Celanese and the Micromax® portfolio of products, visit www.celanese.com.

---

| | | |
|:---|:---|:---|
| **Celanese Contacts:** | | |
| **Investor Relations** | **Media - U.S.** | **Media - Europe** |
| Bill Cunningham | Jamaison Schuler | Petra Czugler |
| Phone: +1 302 772 5231 | Phone: +1 972 443 4400 | Phone: +49 69 45009 1206 |
| <u>william.cunningham@celanese.com</u> | <u>media@celanese.com</u> | <u>petra.czugler@celanese.com</u> |

---

***About Micromax***<sup>®</sup>

*The Micromax® business is a global supplier of advanced electronic inks and pastes designed for high-performance electronics. These materials are used in a variety of applications, including navigation and defense, medical monitoring and advanced circuit board components. Micromax® products are known for durability, flexibility, and performance in harsh environments. The portfolio includes conductive, resistive, and dielectric thick film inks, as well as Low-Temperature Co-fired Ceramic (LTCC) materials for creating multilayer circuits.*

------

***About Celanese***

*Celanese Corporation is a global leader in chemistry, producing specialty material solutions used across most major industries and consumer applications. Our businesses use our chemistry, technology and commercial expertise to create value for our customers, employees and shareholders. We support sustainability by responsibly managing the materials we create and growing our portfolio of sustainable products to meet customer and societal demand. We strive to make a positive impact in our communities and to foster inclusivity across our teams. Celanese Corporation is a Fortune 500 company that employs more than 11,000 employees worldwide with 2024 net sales of $10.3 billion.*

*Forward-Looking Statements*

*The information set forth in this release contains certain "forward-looking statements," which include information concerning the expected timing of the closing of the transaction, Celanese's plans, objectives, goals, future revenues, financial performance, deleveraging efforts, and other information that is not historical information. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that Celanese will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained herein. These include, but are not limited to, Celanese's ability to obtain regulatory approval for and satisfy closing conditions to the transactions described herein, the timing of closing thereof, and Celanese's ability to realize the anticipated benefits of the transactions described herein. Numerous factors, many of which are beyond Celanese's control could cause actual results to differ materially from those expressed as forward-looking statements. Certain of these risk factors are discussed under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 and other filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date it is made, and the Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date the statement is made.*

<br>